Additional vital signs taken during the open-label period, including pulse, blood pressure, and mean arterial pressure Study Description A Phase II, randomized, double-blind, withdrawal to placebo stu
Ceftazidime-avibactam (CAZ-AVI), a novel antibiotic, is effective in treating infections caused by carbapenem-resistant Gram-negative bacteria. However, in patients receiving continuous renal replacem
